SIP sigma pharmaceuticals limited

annual report not impressed by headline figures personally as it...

  1. LZA
    1,858 Posts.
    annual report not impressed by headline figures personally as it includes amalgamation, the bottom line is eps which is only 5.1c, giving a pe of 24 which is too high for a low growth stock at this stage.

    cant see the high previous growth of Arrow continuing, its going to become a yield play, but the 3.6c div is not enough for me.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.